Cite
Tanacli R, Doeblin P, Götze C, et al. COVID-19 vs. Classical Myocarditis Associated Myocardial Injury Evaluated by Cardiac Magnetic Resonance and Endomyocardial Biopsy. Front Cardiovasc Med. 2021;8:737257doi: 10.3389/fcvm.2021.737257.
Tanacli, R., Doeblin, P., Götze, C., Zieschang, V., Faragli, A., Stehning, C., Korosoglou, G., Erley, J., Weiss, J., Berger, A., Pröpper, F., Steinbeis, F., Kühne, T., Seidel, F., Geisel, D., Cannon Walter-Rittel, T., Stawowy, P., Witzenrath, M., Klingel, K., Van Linthout, S., Pieske, B., Tschöpe, C., & Kelle, S. (2021). COVID-19 vs. Classical Myocarditis Associated Myocardial Injury Evaluated by Cardiac Magnetic Resonance and Endomyocardial Biopsy. Frontiers in cardiovascular medicine, 8737257. https://doi.org/10.3389/fcvm.2021.737257
Tanacli, Radu, et al. "COVID-19 vs. Classical Myocarditis Associated Myocardial Injury Evaluated by Cardiac Magnetic Resonance and Endomyocardial Biopsy." Frontiers in cardiovascular medicine vol. 8 (2021): 737257. doi: https://doi.org/10.3389/fcvm.2021.737257
Tanacli R, Doeblin P, Götze C, Zieschang V, Faragli A, Stehning C, Korosoglou G, Erley J, Weiss J, Berger A, Pröpper F, Steinbeis F, Kühne T, Seidel F, Geisel D, Cannon Walter-Rittel T, Stawowy P, Witzenrath M, Klingel K, Van Linthout S, Pieske B, Tschöpe C, Kelle S. COVID-19 vs. Classical Myocarditis Associated Myocardial Injury Evaluated by Cardiac Magnetic Resonance and Endomyocardial Biopsy. Front Cardiovasc Med. 2021 Dec 24;8:737257. doi: 10.3389/fcvm.2021.737257. eCollection 2021. PMID: 35004872; PMCID: PMC8739473.
Copy
Download .nbib